Catalogue number 07460066190, listed by Roche Molecular Systems, Inc., United States, under Dna Probe, Nucleic Acid Amplification, Chlamydia. 1 manufacturer in China is registered for this product code.
Who Else Makes It
Registered in Guangdong. One is registered as a contract manufacturer, able to build to a specification.
Record
Regulatory record for cobas Ctng Qualitative nucleic acid test for use on the cobas 6800/8800 Systems | Listed by | Roche Molecular Systems, Inc., United States |
| FDA product code | MKZ |
| Device type | Dna Probe, Nucleic Acid Amplification, Chlamydia |
| Device class | Class 1 |
| Regulation | 21 CFR 866.3120 |
| Establishment | Specification developer, Manufacturer, Exporter |
| Record published | 2018-04-26 |
| Record revised | 2020-12-21 (version 2) |
Specifications
Specifications | MRI safety | Labeling does not contain MRI Safety Information |
| Single use | Yes |
| Prescription | Prescription only |
| Supplied as a kit | Yes |
| Label carries | lot or batch number, expiry date |
Recalls
The FDA has not published a severity grade for these. Volume alone is not a quality signal: a manufacturer that ships more recalls more.
Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.